Printer Friendly
The Free Library
14,701,494 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Kaken Pharmaceutical to Outsource Entire Distribution Operation to Itochu.


Tokyo, Japan, Nov 2, 2005 - (JCNN JCNN Japan Corporate News Network ) - Kaken Pharmaceutical has decided to outsource the operations of its East Japan Distribution Center to trading giant Itochu. Accordingly, Kaken will relocate re·lo·cate  
v. re·lo·cat·ed, re·lo·cat·ing, re·lo·cates

v.tr.
To move to or establish in a new place: relocated the business.

v.intr.
 the center to Saitama Prefecture Saitama Prefecture (埼玉県 Saitama-ken . The new center will be fully operational from November 21.

With the move, Kaken is to outsource its entire distribution operations to Itochu, which has been undertaking the operations of Kaken's West Japan Distribution Center since May 2003.

Source: JCN JCN Japan Corporate News
JCN Journal of Cognitive Neuroscience
JCN Journal of Cardiovascular Nursing
JCN Journal of Christian Nursing
JCN Job Control Number
JCN Journal of Child Neurology
JCN joint communications network (US DoD) 
 http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Nov 2, 2005
Words:87
Previous Article:Sumitomo Chemical Files Suit Against Pfizer for Amlodipine Besilate.
Next Article:Schering-Plough's TEMODAL Capsule for Glioblastoma Multiforme Granted Priority Review by Government.



Related Articles
Harnessing innovation: corporate VC arms fund smaller companies with big ideas.(Innovation)(venture capital)
The rise of Eizo Kobayashi: and how investing is becoming Itochu's new business line.(UPFRONT)(Cover Story)
Kaken Pharmaceutical to License FIBLAST Wound Healing Agent to Chinese Pharmaceutical.
Shares in Showa Aluminum Powder to be Transferred to the ITOCHU Group.
Kaken Pharmaceutical to License Its Antifungal Compound KP-103 to Dow Pharmaceutical Sciences.
ITOCHU Annual Report to Stakeholders, 'Challenge, Create, Commit - Our Shift to Aggressive Business'.
ITOCHU Announces Investment in Solar Energy Company NorSun.
Akebono Brake Forms Strategic Alliance with ITOCHU.
Akebono Brake Realigns North American and European Businesses.
ITOCHU to Acquire 20% Interest of Kudu Gas Field in Republic of Namibia.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles